207 related articles for article (PubMed ID: 20211558)
21. The rs498872 polymorphism is associated with an elevated susceptibility to glioma: a meta-analysis of 36,264 subjects.
Chen B; Li Y; Chen L; Du Y
Acta Neurol Belg; 2019 Jun; 119(2):239-243. PubMed ID: 30684220
[TBL] [Abstract][Full Text] [Related]
22. Genome-wide association study of glioma and meta-analysis.
Rajaraman P; Melin BS; Wang Z; McKean-Cowdin R; Michaud DS; Wang SS; Bondy M; Houlston R; Jenkins RB; Wrensch M; Yeager M; Ahlbom A; Albanes D; Andersson U; Freeman LE; Buring JE; Butler MA; Braganza M; Carreon T; Feychting M; Fleming SJ; Gapstur SM; Gaziano JM; Giles GG; Hallmans G; Henriksson R; Hoffman-Bolton J; Inskip PD; Johansen C; Kitahara CM; Lathrop M; Liu C; Le Marchand L; Linet MS; Lonn S; Peters U; Purdue MP; Rothman N; Ruder AM; Sanson M; Sesso HD; Severi G; Shu XO; Simon M; Stampfer M; Stevens VL; Visvanathan K; White E; Wolk A; Zeleniuch-Jacquotte A; Zheng W; Decker P; Enciso-Mora V; Fridley B; Gao YT; Kosel M; Lachance DH; Lau C; Rice T; Swerdlow A; Wiemels JL; Wiencke JK; Shete S; Xiang YB; Xiao Y; Hoover RN; Fraumeni JF; Chatterjee N; Hartge P; Chanock SJ
Hum Genet; 2012 Dec; 131(12):1877-88. PubMed ID: 22886559
[TBL] [Abstract][Full Text] [Related]
23. Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility.
Wrensch M; Jenkins RB; Chang JS; Yeh RF; Xiao Y; Decker PA; Ballman KV; Berger M; Buckner JC; Chang S; Giannini C; Halder C; Kollmeyer TM; Kosel ML; LaChance DH; McCoy L; O'Neill BP; Patoka J; Pico AR; Prados M; Quesenberry C; Rice T; Rynearson AL; Smirnov I; Tihan T; Wiemels J; Yang P; Wiencke JK
Nat Genet; 2009 Aug; 41(8):905-8. PubMed ID: 19578366
[TBL] [Abstract][Full Text] [Related]
24. Relation between Established Glioma Risk Variants and DNA Methylation in the Tumor.
Dahlin AM; Wibom C; Ghasimi S; Brännström T; Andersson U; Melin B
PLoS One; 2016; 11(10):e0163067. PubMed ID: 27780202
[TBL] [Abstract][Full Text] [Related]
25. Associations between the rs6010620 polymorphism in RTEL1 and risk of glioma: a meta-analysis of 20,711 participants.
Wu Y; Tong X; Tang LL; Zhou K; Zhong CH; Jiang S
Asian Pac J Cancer Prev; 2014; 15(17):7163-7. PubMed ID: 25227808
[TBL] [Abstract][Full Text] [Related]
26. Effect of CDKN2A/B rs4977756 polymorphism on glioma risk: a meta-analysis of 16 studies including 24077 participants.
Qi X; Wan Y; Zhan Q; Yang S; Wang Y; Cai X
Mamm Genome; 2016 Feb; 27(1-2):1-7. PubMed ID: 26577493
[TBL] [Abstract][Full Text] [Related]
27. Genome-wide high-density SNP linkage search for glioma susceptibility loci: results from the Gliogene Consortium.
Shete S; Lau CC; Houlston RS; Claus EB; Barnholtz-Sloan J; Lai R; Il'yasova D; Schildkraut J; Sadetzki S; Johansen C; Bernstein JL; Olson SH; Jenkins RB; Yang P; Vick NA; Wrensch M; Davis FG; McCarthy BJ; Leung EH; Davis C; Cheng R; Hosking FJ; Armstrong GN; Liu Y; Yu RK; Henriksson R; ; Melin BS; Bondy ML
Cancer Res; 2011 Dec; 71(24):7568-75. PubMed ID: 22037877
[TBL] [Abstract][Full Text] [Related]
28. Distinct germ line polymorphisms underlie glioma morphologic heterogeneity.
Jenkins RB; Wrensch MR; Johnson D; Fridley BL; Decker PA; Xiao Y; Kollmeyer TM; Rynearson AL; Fink S; Rice T; McCoy LS; Halder C; Kosel ML; Giannini C; Tihan T; O'Neill BP; Lachance DH; Yang P; Wiemels J; Wiencke JK
Cancer Genet; 2011 Jan; 204(1):13-8. PubMed ID: 21356187
[TBL] [Abstract][Full Text] [Related]
29. Joint effects between five identified risk variants, allergy, and autoimmune conditions on glioma risk.
Safaeian M; Rajaraman P; Hartge P; Yeager M; Linet M; Butler MA; Ruder AM; Purdue MP; Hsing A; Beane-Freeman L; Hoppin JA; Albanes D; Weinstein SJ; Inskip PD; Brenner A; Rothman N; Chatterjee N; Gillanders EM; Chanock SJ; Wang SS
Cancer Causes Control; 2013 Oct; 24(10):1885-91. PubMed ID: 23903690
[TBL] [Abstract][Full Text] [Related]
30. Transcriptome-wide Mendelian randomization study prioritising novel tissue-dependent genes for glioma susceptibility.
Robinson JW; Martin RM; Tsavachidis S; Howell AE; Relton CL; Armstrong GN; Bondy M; Zheng J; Kurian KM
Sci Rep; 2021 Jan; 11(1):2329. PubMed ID: 33504897
[TBL] [Abstract][Full Text] [Related]
31. The association of 6 variants of 8q24 and the risk of glioma: A meta-analysis.
Tong Y; Ye L; Li S; Zhao F; Ying J; Qu Y; Li J; Mu D
Medicine (Baltimore); 2019 Jul; 98(27):e16205. PubMed ID: 31277128
[TBL] [Abstract][Full Text] [Related]
32. Australian genome-wide association study confirms higher female risk for adult glioma associated with variants in the region of CCDC26.
Alpen K; Vajdic CM; MacInnis RJ; Milne RL; Koh ES; Hovey E; Harrup R; Bruinsma F; Nguyen TL; Li S; Joseph D; Benke G; Dugué PA; Southey MC; Giles GG; Rosenthal M; Drummond KJ; Nowak AK; Hopper JL; Kapuscinski M; Makalic E
Neuro Oncol; 2023 Jul; 25(7):1355-1365. PubMed ID: 36541697
[TBL] [Abstract][Full Text] [Related]
33. Systematic review on the association between ERCC1 rs3212986 and ERCC2 rs13181 polymorphisms and glioma risk.
Zhou CX; Zhao JH
Genet Mol Res; 2015 Mar; 14(1):2868-75. PubMed ID: 25867436
[TBL] [Abstract][Full Text] [Related]
34. Association between DNA repair gene polymorphisms and risk of glioma: a systematic review and meta-analysis.
Adel Fahmideh M; Schwartzbaum J; Frumento P; Feychting M
Neuro Oncol; 2014 Jun; 16(6):807-14. PubMed ID: 24500421
[TBL] [Abstract][Full Text] [Related]
35. Polymorphisms in DNA Repair Gene and Susceptibility to Glioma: A Systematic Review and Meta-Analysis Based on 33 Studies with 15 SNPs in 9 Genes.
Liu K; Jiang Y
Cell Mol Neurobiol; 2017 Mar; 37(2):263-274. PubMed ID: 27055523
[TBL] [Abstract][Full Text] [Related]
36. Pleckstrin homology-like domain family B member 1 rs498872 polymorphism and glioma risk in Chinese Han population.
Zhang JW; Liu ZH; Lin XH; Du YP; Guo HT
Cell Mol Biol (Noisy-le-grand); 2017 Aug; 63(8):7-9. PubMed ID: 28886307
[TBL] [Abstract][Full Text] [Related]
37. Genome-wide association study of glioma subtypes identifies specific differences in genetic susceptibility to glioblastoma and non-glioblastoma tumors.
Melin BS; Barnholtz-Sloan JS; Wrensch MR; Johansen C; Il'yasova D; Kinnersley B; Ostrom QT; Labreche K; Chen Y; Armstrong G; Liu Y; Eckel-Passow JE; Decker PA; Labussière M; Idbaih A; Hoang-Xuan K; Di Stefano AL; Mokhtari K; Delattre JY; Broderick P; Galan P; Gousias K; Schramm J; Schoemaker MJ; Fleming SJ; Herms S; Heilmann S; Nöthen MM; Wichmann HE; Schreiber S; Swerdlow A; Lathrop M; Simon M; Sanson M; Andersson U; Rajaraman P; Chanock S; Linet M; Wang Z; Yeager M; ; Wiencke JK; Hansen H; McCoy L; Rice T; Kosel ML; Sicotte H; Amos CI; Bernstein JL; Davis F; Lachance D; Lau C; Merrell RT; Shildkraut J; Ali-Osman F; Sadetzki S; Scheurer M; Shete S; Lai RK; Claus EB; Olson SH; Jenkins RB; Houlston RS; Bondy ML
Nat Genet; 2017 May; 49(5):789-794. PubMed ID: 28346443
[TBL] [Abstract][Full Text] [Related]
38. Multi-ancestry genome-wide association study of 4069 children with glioma identifies 9p21.3 risk locus.
Foss-Skiftesvik J; Li S; Rosenbaum A; Hagen CM; Stoltze UK; Ljungqvist S; Hjalmars U; Schmiegelow K; Morimoto L; de Smith AJ; Mathiasen R; Metayer C; Hougaard D; Melin B; Walsh KM; Bybjerg-Grauholm J; Dahlin AM; Wiemels JL
Neuro Oncol; 2023 Sep; 25(9):1709-1720. PubMed ID: 36810956
[TBL] [Abstract][Full Text] [Related]
39. The RTEL1 rs6010620 polymorphism and glioma risk: a meta-analysis based on 12 case-control studies.
Du SL; Geng TT; Feng T; Chen CP; Jin TB; Chen C
Asian Pac J Cancer Prev; 2014; 15(23):10175-9. PubMed ID: 25556444
[TBL] [Abstract][Full Text] [Related]
40. Polymorphisms in DNA repair genes and risk of glioma and meningioma.
Luo KQ; Mu SQ; Wu ZX; Shi YN; Peng JC
Asian Pac J Cancer Prev; 2013; 14(1):449-52. PubMed ID: 23534771
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
